nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Atypical behavioural effects of lorazepam: Clues to the design of novel therapies?
|
Giersch, Anne |
|
2010 |
126 |
1 |
p. 94-108 15 p. |
artikel |
2 |
Cannabinoids and the gut: New developments and emerging concepts
|
Izzo, Angelo A. |
|
2010 |
126 |
1 |
p. 21-38 18 p. |
artikel |
3 |
Chemokines, neuronal–glial interactions, and central processing of neuropathic pain
|
Gao, Yong-Jing |
|
2010 |
126 |
1 |
p. 56-68 13 p. |
artikel |
4 |
Dietary flavonoids in cancer therapy and prevention: Substrates and inhibitors of cytochrome P450 CYP1 enzymes
|
Androutsopoulos, Vasilis P. |
|
2010 |
126 |
1 |
p. 9-20 12 p. |
artikel |
5 |
Emerging New Technologies in Pharamcogenomics: Rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1)
|
Ishikawa, Toshihisa |
|
2010 |
126 |
1 |
p. 69-81 13 p. |
artikel |
6 |
Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade
|
Van der Walt, Anneke |
|
2010 |
126 |
1 |
p. 82-93 12 p. |
artikel |
7 |
Neutralizing endogenous chemokines with small molecules
|
Galzi, Jean-Luc |
|
2010 |
126 |
1 |
p. 39-55 17 p. |
artikel |
8 |
Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials
|
Jurasz, Paul |
|
2010 |
126 |
1 |
p. 1-8 8 p. |
artikel |